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Abstract Metarhodopsin II (MII) provides the active confor-
mation of rhodopsin for interaction with the G-protein, Gt.
Fourier transform infrared spectra from samples prepared by
centrifugation reflect the pH dependent equilibrium between MII
and inactive metarhodopsin I. C-terminal synthetic peptides
(GtK(340^350) and GtQ(60^71)farnesyl) stabilize MII. We find
that both peptides cause similar spectral changes not seen with
control peptides (GtK (K341R, L349A) and non-farnesylated
GtQ). The spectra reflect all the protonation dependent bands
normally observed when MII is formed at acidic pH. Beside the
protonation dependent bands, additional features, similar with
both peptides, appear in the amide I and II regions.
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1. Introduction
Rhodopsin absorbs photons to trigger the amplifying cas-
cade of vision by coupling to the G-protein transducin (Gt).
The light-sensitive ground state conformation of rhodopsin is
stabilized by a salt bridge between the protonated Schi¡ base
bond of the 11-cis-retinal to Lys296 and its counterion at
Glu113 [1^3]. Cis/trans isomerization and relaxation through
intermediates results in the protonation dependent ‘metarho-
dopsin’ states. Metarhodopsin I (MI), in which the Schi¡ base
is still protonated, remains in a pH and temperature depen-
dent equilibrium with the subsequent metarhodopsin II (MII)
intermediate [3,4] which is the only form with a deprotonated
Schi¡ base, re£ected in its blue-shifted UV/Vis absorption [5].
The conversion to MII is coupled to proton transfer from the
Schi¡ base, most likely to its counterion, Glu113 [2] and to
proton uptake from solution, with the highly conserved resi-
due Glu134 as the likely proton acceptor [6]. The kinetic di¡er-
ence between both reactions [7,8] and their decoupling in
Glu134 mutants [6] have suggested that the two proton transfer
events do not occur in one common proton relay but are
rather thermodynamically coupled, yielding MII subforms
MIIa and MIIb.
UV/Vis spectroscopy and photoregeneration experiments
have shown that bound G-protein stabilizes MII (identi¢ed
by its 380 nm absorption) at the expense of MI (forming
‘extra MII’). Synthetic peptides from the GtK and GtQ C-ter-
minal sequences can replace the Gt holoprotein in this regard
[9], suggesting that the respective structures on the Gt holo-
protein are interaction sites for rhodopsin. UV/Vis spectros-
copy can provide information about the protonation state of
the Schi¡ base but does not re£ect directly the additional
proton transfer reactions linked to MII formation. Fourier
transform infrared (FTIR) di¡erence spectroscopy allows to
identify individual molecular changes that occur during pho-
toproduct formation [10]. This study will show that such
changes can be titrated as a function of pH in ‘wet’ samples
prepared by centrifugation. The spectral features are com-
pared to those induced by the binding of K- or Q-C-terminal
peptides. Finally, the subtle di¡erences between the spectra of
the K- and Q-stabilized species will be considered.
2. Materials and methods
2.1. Isolation of bovine rod outer segments
Bovine reactive oxygen species (ROS) were prepared from fresh,
dark-adapted retinas obtained from a local slaughterhouse by means
of a discontinuous sucrose gradient method [11]. Retinas were dis-
sected, and ROS were isolated under dim red illumination. All sub-
sequent procedures were performed at 4‡C.
2.2. Puri¢cation of rhodopsin
Rhodopsin membranes were prepared by removing the soluble and
membrane-associated proteins from ROS membranes by repetitive
washes with a low ionic strength bu¡er [12]. All steps were performed
under dim red illumination. The membrane suspension was stored at
380‡C until use.
2.3. Sample preparation
In a routinely applied preparation technique, a drop of the mem-
brane suspension is dried onto an infrared (IR) transmissive material
and rehydrated with a small amount of water [13,14]. This leads to
very stable di¡erence spectra, which are, however, in many cases in-
sensitive to pH [15]. Generally, the capability of rhodopsin to form
di¡erent intermediates depends crucially on the water content of the
sample ([16] and own observations). Although the samples are rehy-
drated, irreversible changes in the hydration and thus protonation
may occur. Even if the ¢lm is in contact with bulk water after the
drying procedure (as for example in ATR spectroscopy [17,18]), the
measured MI/MII equilibrium, by both the IR and the UV/Vis cri-
teria, does not show the sensitivity to pH known from free membrane
suspension (C. Meyer, E. Ritter and F. Bartl, unpublished observa-
tions).
We applied a centrifugation procedure according to [19], with mod-
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i¢cations. For a single experiment, ca. 70 Wl of a 0.15 mM rhodopsin
stock solution of washed membranes was used. For sample prepara-
tion, pH was adjusted by adding a few Wl of diluted NaOH or HCl.
Then the suspension was centrifuged for 25 min at 100 000Ug to form
a tightly packed pellet. The bu¡er solution was removed and the pellet
was transferred to a 30 mm diameter BaF2 window without any dry-
ing. The concentration of rhodopsin in the pellet was calculated to 2.2
mM by its visible absorbance spectra at 500 nm. The concentration
was determined in the same sample and cuvette as used for IR spec-
troscopy. Then the window was assembled into a vacuum-sealed cell
using a 5 Wm PTFE-gasket and a second BaF2 window, and placed
into a temperature-controlled cell holder. For extra MII measure-
ments, the rhodopsin pellet was resuspended in a 3 mM solution
(100 Wl) of the respective peptide. Then, after adjusting the pH as
described, this suspension was centrifuged again for 25 min at
100 000Ug. The ¢nal peptide concentration in the pellet was estimated
Fig. 1. FTIR analysis of the pH dependence of MII formation. FTIR di¡erence spectra of [rhodopsin (illuminated)]3[rhodopsin (dark-
adapted)] at 1‡C, (a) pH 5.0, (b) pH 6.0, (c) pH 7.2, (d) pH 8.2. Spectra are arbitrarily shifted along the ordinate. Inset: [MII]/([MI]+[MII])
from a least square ¢t to di¡erence spectra, plotted as a function of pH at 1‡C and 5‡C. Solid lines through the data are ¢rst order hyperbolic
¢ts.
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2.5 mM assuming that its amount was proportional to the water
content.
2.4. Peptides
Peptide synthesis and puri¢cation were as described before [20]. The
lyophilized peptides were dissolved in deionized water and the desired
pH was adjusted with diluted NaOH.
Amino acid sequences for the peptides were as follows: GtK(340^
350), IKENLKDCGLF; high a⁄nity analog (HAA) GtK(340^350),
VLEDLKSCGLF; GtK(340^350) control, IRENLKDCGAF;
GtQ(60^71)farnesyl, DKNPFKELKGGC-farnesyl. GtQ(60^71) con-
trol, DKNPFKELKGGC. The peptide is homogeneously dissolved
in the suspension bu¡er.
2.5. FTIR measurements
All measurements were performed with a Bruker IFS 113v spec-
trometer using an LN2-cooled HgMnTe-detector (EGpG Judson,
J15D-series). Water content and equilibration were monitored by re-
cording the intensity of the OH stretching vibration band at 3400
cm31 during the experiment.
After an equilibration time of ca. 3 h, a set of 20 transmission
spectra was recorded, each consisting of 64 scans. The sample was
then photobleached for 20 s with a 150 W ¢ber-optic light source (LQ
1600, Spindler and Hoyer, Go«ttingen, Germany) operating at full
power. 10 s after illumination, a second set of 20U64 scans was
recorded under the same conditions. Spectra were setwise averaged
and the di¡erence spectrum was then generated by subtracting the
spectrum of the dark-adapted sample from that of the illuminated
sample. All di¡erence spectra are the average of at least three di¡erent
sets of spectra from separate samples. The proportion between MI
and MII in the di¡erence spectra was calculated by a least square ¢t,
using MI and MII base spectra measured under the following con-
ditions: MI: pH 8.2, T = 1‡C, yielding 99.4% MI; MII: pH 4.5,
T = 10‡C, yielding 98.5% MII, according to [4].
3. Results
3.1. pH dependent FTIR di¡erence spectra re£ect the MI/MII
equilibrium
We recorded two sets of FTIR di¡erence spectra (spectrum
after illumination minus spectrum of the dark-adapted sam-
ple) at pH values between 4.9 and 8.2, and temperatures 1‡C
and 5‡C. A typical set of spectra recorded at 1‡C is shown in
Fig. 1. The spectrum at pH 5.0 and 1‡C shows characteristic
absorption bands in the spectral range between 1780 cm31
and 1700 cm31 where the CNO stretching vibrations of pro-
tonated carbonyl groups appear. The bands at 1767 cm31
(negative, (3)) and 1745 cm31 (+), and at 1730 cm31 (3)
are caused by changes in hydrogen bonds of Asp83 and
Glu122 and the positive band at 1713 cm31 (+) is due the
protonation of the Schi¡ base counterion Glu113. The strong
positive absorptions at 1644 cm31 and at 1532 cm31 and
negative bands at 1620 cm31 and 1555 cm31 can also be
assigned to MII and show that the intermediate MII is formed
quantitatively under these conditions [10]. With increasing
pH, one observes the rise of the positive bands at 951 cm31,
1538 cm31, 1702 cm31, of the negative doublet at 1737 cm31
and 1726 cm31, and of a negative band at 1550 cm31, all
indicating a growing amount of MI [21]. Control UV/Vis
spectra were recorded from identical samples, or aliquots,
with the same result (data not shown).
The Inset in Fig. 1 shows the relative amount of MII as a
function of pH, from a least squares ¢t to the IR spectra
recorded at 1‡C and 5‡C. Hyperbolic ¢ts to the data (solid
lines) yield titration curves with apparent pKa values 6.38 and
6.54 for 1‡C and 5‡C, respectively, in agreement with the MI/
MII equilibrium [4].
3.2. Both, GtK and GtQ peptides a¡ect the protonation depen-
dent MI/MII equilibrium
Having established the pH dependence of MII in FTIR, we
went on to examine the in£uence of GtK- and of GtQ-derived
peptides on the pH dependent MI/MII equilibrium. This ex-
tends existing FTIR information on the e¡ect measured with
di¡erent analogs of the GtK-derived C-terminal peptide using
ATR spectroscopy [18] or transmission spectra at low temper-
atures [19].
Fig. 2a shows experiments with GtK(340^350) peptides. In
the absence, a virtually pure MI di¡erence spectrum (see
above) is seen, as expected under the conditions (pH 8.2,
1‡C; Fig. 2a (dotted line)). In the presence of a saturating
amount of GtK(340^350) peptide (Fig. 2a, solid line), a clear
MII spectrum is seen, including all features observed at acidic
pH. This demonstrates that the GtK(340^350) peptide is e¡ec-
tive in stabilizing MII. The same di¡erence spectra were meas-
ured with the HAA of the GtK-derived peptide (data not
shown). The di¡erence spectra in the absence and presence
of a GtK(340^350) control peptide (Fig. 2b, dotted and solid
lines, respectively; pH 8.2 and 1‡C) are identical within the
accuracy of the measurement, indicating the expected lack of
an e¡ect towards MII formation [9]. It also proves that no
unspeci¢c interaction of the peptides with the labile MI/MII
equilibrium occurs.
The spectrum recorded with the Q-peptide (solid line in Fig.
2c) displays all characteristic MII features as described in Fig.
1a, demonstrating that the Q-derived peptide is also able to
stabilize MII. For comparison, the di¡erence spectrum of the
peptide-free sample is shown (dotted line in Fig. 2c, same as in
Fig. 2a). A control peptide lacking the farnesyl moiety has no
e¡ect on extra MII formation in UV/Vis spectroscopy [9]. Fig.
2d shows the analogous behavior in FTIR.
3.3. Comparison of MII and extra MII spectra
Fig. 3 compares spontaneously formed MII at pH 5.5 with
extra MII at pH 8.2 and 1‡C, induced by native GtK- and
GtQ-far peptides. The subtracted spectra of the complexes
with GtK and GtQ peptide show a conserved pattern in the
amide I region between 1700 cm31 and 1620 cm31, which
indicates that the complex formation with GtK and GtQ pep-
tide induces similar structural changes. The negative bands at
1687 cm31 and 1642 cm31 are accompanied with a positive
band at 1657 cm31.
The bands from 1480 cm31 to 1580 cm31 cover the struc-
turally sensitive amide II region (a coupled mode including C^
N stretching and N^H bending vibrations). For the complexes
with peptides, the amide II region shows characteristic bands
at 1572 cm31 (3), 1529 cm31 (3) and 1551 cm31 (+), in
agreement with [19]. The MII/GtQ-far complex does not
show the negative bands at 1572 cm31 and at 1529 cm31 to
the extent seen with the K-peptide, but shares the positive
band at 1551 cm31.
4. Discussion
4.1. GtK and GtQ C-terminal peptides evoke the FTIR bands of
MII
The data show that pH titration of FTIR samples yields an
ensemble of spectral features that follows the pH and temper-
ature dependence known from UV/Vis spectrophotometry [4]
and proton uptake [7]. The spectral ¢ngerprint of protonated
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MII thereby obtained includes not only the proton transloca-
tion at the retinal Schi¡ base but also the related structural
changes re£ected in the reorientation of hydrogen bonds. This
information provided the basis for comparing the protonated
and peptide-stabilized forms of MII.
The data have shown that the GtK and GtQ C-terminal
peptides fail to stabilize any species other than the protonated
MII, as it is spontaneously formed at low pH. Protonation
dependent spectral features include the band at 1713 cm31,
indicating the protonation of the Schi¡ base counterion
Glu113, and the features re£ecting changes in hydrogen bond-
ing of residues Asp83 and Glu122. Properties of Schi¡ base
Fig. 2. Extra MII formation by interaction with the GtK C-terminal peptide. a: solid line: FTIR di¡erence spectra of [rhodopsin (illumina-
ted)]3[rhodopsin (dark-adapted)] at 1‡C and pH 8.2 in the presence of GtK(340^350) native peptide (IKENLKDCGLF); dotted line: di¡erence
spectra in the absence of peptide, under the same conditions. b: solid line: FTIR di¡erence spectra of [rhodopsin (illuminated)]3[rhodopsin
(dark-adapted)] at 1‡C and pH 8.2 in the presence of GtK(340^350)-derived control peptide (IRENLKDCGAF); dotted line: di¡erence spectra
in the absence of peptide, under the same conditions. c: dotted line: FTIR di¡erence spectra of [rhodopsin (illuminated)]3[rhodopsin (dark-
adapted)] at 1‡C and pH 8.2, in the presence of GtQ(60^71)farnesyl-derived peptide; solid line: FTIR di¡erence spectra of [rhodopsin (illumina-
ted)]3[rhodopsin (dark-adapted)] at 1‡C and pH 8.2 in the presence of (DKNPFKELKGGC-farnesyl). d: dotted line: FTIR di¡erence spectra
of [rhodopsin (illuminated)]3[rhodopsin (dark-adapted)] at 1‡C and pH 8.2. solid line: FTIR di¡erence spectra of [rhodopsin (illuminated)]3
[rhodopsin (dark-adapted)] at 1‡C and pH 8.2 in the presence of GtQ-derived control peptide (same peptide as in c, without farnesyl group).
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protonated (i.e. MI-like) species are not detectable. Thus the
data do not support a role of the MII subform MIIa [7] or of
a MI-like species (MIb [22]) in the two site interaction [9] with
Gt. This does not exclude that binding sites other than the K-
and Q-C-termini [23] may interact with earlier intermediates.
4.2. Peptide interaction sites at MII
The speci¢c stabilization of protonated MII by both pep-
tides tested implies that these short stretches from the GtK
and GtQ sequences have the capacity to recognize the proto-
nated MII species and to distinguish it from the other inter-
mediates. A small percentage of the free peptide may have a
conformation that ¢ts better to protonated MII than to MI
and the other intermediates [24]. Alternatively, the related
receptor binding sites form a non-linear epitope only in
MII. Light-induced microstructural changes were indeed de-
tected by EPR and speci¢ed for the MII state [25], and the
exposure of an epitope for an antibody speci¢c for the light-
activated state has been described [26].
Recent analyses draw attention to the fourth cytoplasmic
loop of rhodopsin. With the same GtK and GtQ peptides as in
the present investigation, a stabilizing e¡ect was found as long
as an intact fourth loop structure was present, independent of
whether the primary sequence was from rhodopsin or the L2
receptor [27]. An FTIR analysis of these mutants may o¡er
the chance to elucidate the mechanism of interaction. Binding
Fig. 3. Comparison of spontaneously formed MII (pH 5.0) with extra MII formed by peptide interaction (pH 8.2). Dotted lines in a and c: dif-
ference spectrum [rhodopsin (illuminated)]3[rhodopsin (dark-adapted)] at 1‡C, pH 5.0, identical to Fig. 1a, for comparison. a: solid line: di¡er-
ence spectrum with GtK(340^350) native peptide (same as in Fig. 2a); b: subtraction of the spectra in a: [extra MII3spontaneously formed
MII]. c: solid line: di¡erence spectrum with GtQ(60^71)farnesyl-derived peptide (same as in Fig. 2a); d: subtraction of the spectra in c: [extra
MII3spontaneously formed MII]. e: Baselines obtained by subtraction of two spectra recorded under the following conditions: top: subtrac-
tion of two rhodopsin/MII di¡erence spectra, bottom: subtraction of two rhodopsin/MI spectra with and without control peptide.
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of Gt to R* depends also on an intact second and third
cytoplasmic loop [28]. A most critical region is close to the
likely proton acceptor, Glu134. FTIR features that appear in
polarized IR di¡erence spectra have now been tentatively as-
signed to Glu134 [29], and peptide stabilization experiments
with this technique may be envisaged.
4.3. Di¡erences between the peptide-induced spectral changes
The subtracted spectra in Fig. 3 show that the interaction
between the peptides and photoactivated rhodopsin induces
some positive and negative bands that do not appear in the
pH dependent spectra. With the K-peptide, speci¢c motifs
appear in the amide I and amide II regions. These features,
which are also seen with the Q-peptide, although less pro-
nounced, indicate changes of secondary structure. The nega-
tive bands at 1687 cm31 and at 1642 cm31 could indicate turn
and bend conformations of the peptide before binding to the
receptor [30]. An induced formation of an K-helical binding
motif in the GtK peptide was deduced from nuclear magnetic
resonance transfer NOESY spectroscopy [31]. The peptide-in-
duced FTIR band at 1657 cm31 (see Fig. 3) was accordingly
assigned to an induced formation of K-helix [19]. Our results
would then suggest that a similar event occurs with the Q-
peptide. This structure has a role in both membrane anchor-
ing and interaction with the receptor (see [32] and citations
therein). Conceivably, the transition from the membrane to
the receptor bound state could induce a more helical confor-
mation of the C-terminal GtQ structure, but it cannot be ex-
cluded that such a structural change occurs in the related
receptor site. To discriminate between the two possibilities,
labeled peptides will have to be applied.
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